Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2012
10/09/2012CA2674803C Quinazoline derivatives as angiogenesis inhibitors
10/09/2012CA2556944C Thiazole derivative
10/09/2012CA2476594C Mono-and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/07/2012CA2738357A1 Methods and compositions to promote ocular health
10/04/2012WO2012134187A2 Pharmaceutical composition for preventing or treating macular degeneration
10/04/2012WO2012133896A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012US20120252891 Vanilloid Fatty Hydroxamates as Therapeutic Anti-inflammatory Pharmaceuticals
10/04/2012US20120252875 Methods and compositions for treating diseases, disorders or injury of the cns
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252868 Novel means and methods for the treatment of hearing loss and phantom hearing
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252842 Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252830 Substituted Aminobutyric Derivatives as Neprilysin Inhibitors
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252810 Fatty acid non-flushing niacin derivatives and their uses
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252773 Method and composition for inhibiting cell proliferation and angiogenesis
10/04/2012US20120252771 Implants and methods for treating inflammation-mediated conditions of the eye
10/04/2012US20120252759 Thiazole derivatives for the treatment of diseases such as cancer
10/04/2012US20120252756 Pharmaceutical Compositions and Methods for Treating, Controlling, Ameliorating, or Reversing Conditions of the Eye
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252720 Compositions for treatment of ear disorders and methods of use thereof
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251638 Nutritional Supplement Comprising Nut Oil Composition
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251576 Treatment of Nasal and Sinus Disorders
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120251461 [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
10/04/2012DE102011015567A1 Dosage forms, useful e.g. for the acute treatment of stress-induced pathologies in the central nervous system and cardiovascular system, comprise beta blockers, which are in the form of liquid aerosols
10/04/2012CA2831771A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012CA2831454A1 Modulators of plexin b2 activity
10/04/2012CA2831025A1 Pharmaceutical composition for preventing or treating macular degeneration
10/03/2012EP2506008A1 Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
10/03/2012EP2504313A1 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
10/03/2012EP2504025A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012CN1972714B Methods of treating autoimmune and inflammatory diseases
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712584A 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
10/03/2012CN102711771A Combination, kit and method of reducing intraocular pressure
10/03/2012CN102711758A 5-(1H-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102711748A Pharmaceutical combination of prostaglandin compound and NSAID for the treatment of glaucoma and ocular hypertension
10/03/2012CN102702210A Application of phthalocyanine metal complex containing piperazine ethyoxyl modified groups
10/03/2012CN102702119A Pharmaceutical combinations of an angiotensin receptor antagonist and an NEP inhibitor
10/03/2012CN102702070A Solid form containing (+)-2-[1-(3-oxethyl-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, composition and application thereof
10/03/2012CN102698079A Medicine composition for treating xerophthalmia and preparation method and application thereof
10/03/2012CN102698023A Medicament for treating cataract
10/03/2012CN102697986A Tibetan medicine for treating vernal keratoconjunctivitis
10/03/2012CN102697983A Combined tablet for clearing away heat and toxic materials
10/03/2012CN102697966A Traditional Chinese medicine for curing tinnitus
10/03/2012CN102697927A Cold-pungent tablet for resolving fleshy exterior
10/03/2012CN102697901A Fructus crataegi leaf and novel application of extract of fructus crataegi leaf
10/03/2012CN102697851A Medicament for treating ocular surface disease
10/03/2012CN102697792A Sustained releasing medicine for treating glaucoma and preparation technology of same
10/03/2012CN102697750A Tiopronin enteric-coated tablet and preparation method thereof
10/03/2012CN102697713A Sodium hyaluronate eye drops and a preparation method thereof
10/03/2012CN102697709A Diclofenac nanometer eye drop and preparation method thereof
10/03/2012CN102228428B Large volume injection composition containing vinpocetine and preparation method thereof
10/03/2012CN102210856B Collagen eye drops and preparation method thereof
10/03/2012CN102078343B Application of ginkgo leaf total lactones in preparation of medicament for preventing or treating deafness and tinnitus
10/03/2012CN102014920B Eye-drop preparation and use thereof
10/03/2012CN101933996B Chinese medicinal composition having effects of clearing heat, relieving fire and eliminating toxins and preparation and detection methods thereof
10/03/2012CN101822712B Pellet for oral administration and external use and preparation process thereof
10/03/2012CN101472597B Inhibitor of expression of nuclear transcription factor AP-1, and pharmaceutical product and product using the inhibitor
10/03/2012CN101385697B Flurbiprofen axetil eye nano-emulsion in-situ gel preparation and preparation method thereof
10/03/2012CN101257899B Application of alkamine compound in the preparation of drugs of autoimmune diseases
10/02/2012US8278348 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
10/02/2012US8278339 Valsartan salts
10/02/2012CA2466477C A2b adenosine receptor antagonists
09/2012
09/27/2012WO2012127927A1 Medical device for controlled release of drug
09/27/2012WO2012126472A1 Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases
09/27/2012WO2012126369A1 Dna, recombinant vector containing the same, cell, composition and use thereof
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012094300A3 Methods of treating age-related macular degeneration
09/27/2012WO2012092320A3 Eye treatment
09/27/2012WO2012078525A3 Compositions and methods for treating ophthalmic conditions
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245231 Weight based dosing of an oral solution having diphenhydramine, or pharmaceutically acceptable salts thereof, as an active ingredient
09/27/2012US20120245227 Pharmaceutical compositions having desirable bioavailability
09/27/2012US20120245217 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
09/27/2012US20120245206 Multi-cyclic compounds and methods of use
09/27/2012US20120245187 Heterobicyclic carboxamides as inhibitors for kinases
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245113 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245108 Method of modulating complement factor b (cfb) expression in cells
09/27/2012US20120245102 Partial peptide of lacritin
09/27/2012US20120245097 Use of pedf-derived polypeptides for promoting stem cells proliferation and wound healing
09/27/2012US20120245090 Method for screening an agent being useful for the treatment of dry eye and / or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 531